European Drug Administration: Novo Nordisk says the shortage of diabetes drugs will last until 2024
王俊杰2017
发表于 2023-11-22 10:26:09
353
0
0
[European Drug Administration: Novo Nordisk said that the shortage of diabetes drugs will last until 2024] The European Drug Administration (EMA) released a note on November 21 local time, saying that Novo Nordisk said that due to capacity constraints and increased demand, the shortage of its diabetes drugs "Ozempic" and "Victoza" will worsen in the fourth quarter of 2023 and will continue until 2024. In order to increase the supply of Novotel, the company has decided to temporarily reduce the supply of Novotel.
LogoMoney.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表LogoMoney.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表LogoMoney.com立场，且不构成建议，请谨慎对待。
猜你喜欢
- Novo Nordisk has participated in the CIIE for seven consecutive years, working together with various sectors to promote the concept of "healthy metabolism"
- Novo Nordisk warns of the risk of compound generic semaglutide, which has caused 10 deaths and 100 hospitalizations
- Lai Lai scares, Novo Nordisk saves the scene! The market prospects of weight loss drugs still make many players salivate
- European Central Bank Management Committee: There are sufficient reasons to cut interest rates in December, and future policies may shift towards stimulus
- Global highlights for next week: European Central Bank opens year-end interest rate meeting curtain, AI application plays multiple major roles
- Novo Nordisk: All regulatory delivery conditions for Novo Nordisk's $16.5 billion acquisition of Contante have been met
- Novo Nordisk invests 8.5 billion Danish kroner to build new production facility in Odense, Denmark
- Novo Nordisk's pre-market decline narrows to 20%
- Overseas Weekly | Luckin Coffee opens five branches in Hong Kong simultaneously; Xiaopeng Motors delivered over 10000 units in Europe
- Major changes in the European energy market! The United States is attempting to replace Russia's natural gas exports to Europe
-
美股市场：纽约股市三大股指4月30日涨跌不一。截至当天收盘，道琼斯工业平均指数比前一交易日上涨141.74点，收于40669.36点，涨幅为0.35%；标准普尔500种股票指数上涨8.23点，收于5569.06点，涨幅为0.15%；纳斯 ...- joey791216
- 前天 11:57
- 支持
- 反对
- 回复
- 收藏
-
当地时间周四，美股三大股指集体收涨，其中道指和标普500指数实现“八连涨”。不过，三大股指均在尾盘出现小幅跳水。 苹果、亚马逊于周四美股盘后公布了最新业绩，尽管业绩有所超出预期，但仍有令市场不满 ...- jiangu12
- 昨天 10:28
- 支持
- 反对
- 回复
- 收藏
-
5月2日，全球电商巨头亚马逊公布了2025年第一季度财报。亚马逊第一季度净销售额为1556.67亿美元，较2024年第一季度同比增长9%；净利润为171.27亿美元，较2024年第一季度增长64%；每股摊薄收益1.59美元，较上年同 ...- 独品金莲芳
- 6 小时前
- 支持
- 反对
- 回复
- 收藏
-
周三热门中概股涨跌不一。纳斯达克中国金龙指数（HXC）收跌0.95%。 上涨股当中（按市值从高到低），台积电涨1.34%，阿里巴巴涨0.46%，拼多多涨1.36%，网易涨0.66%，中华电信涨1.33%，理想汽车涨0.91%，日月 ...- 蓝蓝的彩
- 前天 11:15
- 支持
- 反对
- 回复
- 收藏
